0001144204-19-009923.txt : 20190225 0001144204-19-009923.hdr.sgml : 20190225 20190225173639 ACCESSION NUMBER: 0001144204-19-009923 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190219 FILED AS OF DATE: 20190225 DATE AS OF CHANGE: 20190225 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Beebe Katherine CENTRAL INDEX KEY: 0001768867 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13341 FILM NUMBER: 19630747 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BLVD, SUITE 505 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000910267 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502444990 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 3 1 tv514643_3.xml OWNERSHIP DOCUMENT X0206 3 2019-02-19 0 0000910267 TITAN PHARMACEUTICALS INC TTNP 0001768867 Beebe Katherine 400 OYSTER POINT BLVD., SUITE 505 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Scientific Officer Common Stock 2387 D Option (Right to Buy) 1.56 Common Stock 28487 D Option (Right to Buy) 19.80 2025-03-16 Common Stock 4243 D Option (Right to Buy) 5.82 2028-03-07 Common Stock 28335 D Represents currently vested options that were granted between May 2009 and February 2017 that were repriced effective January 23, 2019. Of such options, 7,576 expire on May 17, 2019, with the balance expiring on various dates between May 11, 2021 and February 13, 2027. These options, which were granted in March 2015, are fully vested. These options, which were granted in March 2017, are fully vested. /s/Katherine Beebe DeVarney 2019-02-25